carisoprodol

carisoprodol
Clinical data
Pronunciation	/kərˌaɪsʌˈproʊdɒl/; kər-EYE-suh-PROH-dol
Trade names	Soma, others
AHFS/Drugs.com	Monograph
MedlinePlus	a682578
License data	US DailyMed: Carisoprodol;
Addiction; liability	LowSablon:failed verification
Routes of; administration	By mouth
Drug class	Muscle relaxant
ATC code	M03BA02 (WHO) ;
Legal status
Legal status	AU: S4 (Prescription only); CA: ℞-only; US: Schedule IV;
Pharmacokinetic data
Protein binding	60%
Metabolism	Liver (CYP2C19-mediated)
Metabolites	Meprobamate
Onset of action	Rapid (30 minutesSablon:failed verification)
Elimination half-life	2.5 hours [12 hoursSablon:refn]
Excretion	Kidney
Identifiers
	IUPAC name (RS)-2-{[(aminocarbonyl)oxy]methyl}-2-methylpentyl isopropylcarbamate;
CAS Number	78-44-4 ;
PubChem CID	2576;
IUPHAR/BPS	7610;
DrugBank	DB00395 ;
ChemSpider	2478 ;
UNII	21925K482H;
KEGG	D00768 ;
ChEBI	CHEBI:3419 ;
ChEMBL	ChEMBL1233 ;
Chemical and physical data
Formula	C12H24N2O4
Molar mass	260.334 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(N)OCC(C)(CCC)COC(=O)NC(C)C;
	InChI InChI=1S/C12H24N2O4/c1-5-6-12(4,7-17-10(13)15)8-18-11(16)14-9(2)3/h9H,5-8H2,1-4H3,(H2,13,15)(H,14,16) ; Key:OFZCIYFFPZCNJE-UHFFFAOYSA-N ;
	(verify)

Angol

carisoprodol (tsz. carisoprodols)